|
A "Pre-Enrollment" Protocol for HIV-Infected Adolescents Clinical Trials Information presented on Clinical Trials Search isn't intended to be a substitute for proven healthcare advice, trips or treatment using a real physician. We are not docs. Always confer with your mD on A "Pre-Enrollment" Protocol for HIV-Infected Adolescents conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. A "Pre-Enrollment" Protocol for HIV-Infected Adolescents Clinical research trials and A "Pre-Enrollment" Protocol for HIV-Infected Adolescents medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectiveness of new drugs. The intention of the studies / projects is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector corporations to detect remedies for all forms of circumstances, like A "Pre-Enrollment" Protocol for HIV-Infected Adolescents. A "Pre-Enrollment" Protocol for HIV-Infected Adolescents Clinical Trials and other clinical trials allow for volunteers to undergo healthcare treatment options before they are available to the masses. Most times the participants receive treatment for free, and every now and again they are paid for their time. Occasionally there is a cost for a A "Pre-Enrollment" Protocol for HIV-Infected Adolescents clinical trial. Subjects typically recieve the finest healthcare available for their A "Pre-Enrollment" Protocol for HIV-Infected Adolescents condition. Hazards are a reality, nonetheless, and might include more or frequent mD trips, health risks (potentially life-endangering), and/or the treatment being ineffective. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A "Pre-Enrollment" Protocol for HIV-Infected Adolescents  A "Pre-Enrollment" Protocol for HIV-Infected Adolescents
A "Pre-Enrollment" Protocol for HIV-Infected Adolescents
For Condition: HIV Infections
Status: Completed
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: PRIMARY: To identify, characterize, and co-enroll HIV-infected adolescents into existing and future ACTG (or other NIH-sponsored) HIV treatment protocols through the systematic and recurrent assessment of eligibility. To assess the ability of adolescents enrolled in ACTG 220 to adhere to ACTG (or other NIH-sponsored) HIV treatment protocols; and to define factors that influence the adolescent's ability to enter or adhere to study protocols. SECONDARY: To describe the nature, stage, and progression of HIV infection in adolescents. Little is known about HIV-infected adolescents as a group and, as a result, small numbers of them are currently enrolled in ACTG drug studies. Creative approaches are needed to encourage enrollment of HIV-infected adolescents whose socio-demographic profile has made access to NIH-sponsored research unlikely.
Details: Little is known about HIV-infected adolescents as a group and, as a result, small numbers of them are currently enrolled in ACTG drug studies. Creative approaches are needed to encourage enrollment of HIV-infected adolescents whose socio-demographic profile has made access to NIH-sponsored research unlikely. At entry and at every subsequent visit, participants are systematically evaluated for eligibility and willingness to enter ACTG (or other NIH-sponsored) HIV treatment protocols from a menu developed and updated by the Pediatric Adolescent Working Group of the ACTG. A survey of participant attitudes, behaviors, and beliefs is administered and updated semiannually. Participants attend clinic visits every 3 months and are followed for a minimum of 6 months, until the end of the study. They receive periodic physical exams, STD and gynecologic or genitourinary evaluations, HIV symptom assessment and related diagnoses, TB evaluation, and laboratory tests (hematology and immunology).
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: 13 Years/20 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Participants must meet the following criteria: - HIV infection. - NOT currently enrolled in an ACTG treatment protocol. Exclusion Criteria Co-existing Condition: Participants with the following condition are excluded: - No legal provision for consent to participate in clinical research can be determined.
Total Enrollment: 250
Location and Contact Information:
Overall Study Official:
D'AngeloLJ, Study Chair,
Emory Univ Hosp / Pediatrics
Atlanta, Georgia, 30306
United States
Univ of Cincinnati
Cincinnati, Ohio, 452670405
United States
Milton S Hershey Med Ctr
Hershey, Pennsylvania, 170330850
United States
Tulane Univ / Charity Hosp of New Orleans
New Orleans, Louisiana, 701122699
United States
Univ Texas Health Science Ctr / Univ Texas Med School
Houston, Texas, 77030
United States
UCSF / Moffitt Hosp - Pediatric
San Francisco, California, 941430105
United States
King's County Hosp Ctr / Pediatrics
Brooklyn, New York, 11203
United States
Univ of Puerto Rico / Univ Children's Hosp AIDS
San Juan, , 009365067
Puerto Rico
Duke Univ Med Ctr
Durham, North Carolina, 277103499
United States
Bellevue Hosp / New York Univ Med Ctr
New York City, New York, 10016
United States
Los Angeles County - USC Med Ctr
Los Angeles, California, 90033
United States
Children's Hosp of Los Angeles/UCLA Med Ctr
Los Angeles, California, 900276016
United States
Worcester Memorial Hosp / Med Ctr of Cntrl MA-Memorial
Worcester, Massachusetts, 01605
United States
Cincinnati Children's Hosp / Univ Hosp
Cincinnati, Ohio, 452292899
United States
Great Lakes Hemophilia Foundation
Wauwatosa, Wisconsin, 532130127
United States
Children's Hosp of Los Angeles
Los Angeles, California, 90027
United States
Long Beach Memorial (Pediatric)
Long Beach, California, 90801
United States
Mount Sinai Med Ctr / Pediatrics
New York City, New York, 10029
United States
Boston City Hosp / Pediatrics
Boston, Massachusetts, 02118
United States
Harlem Hosp Ctr
New York City, New York, 10037
United States
Univ of Chicago Children's Hosp
Chicago, Illinois, 606371470
United States
Children's Hosp of Philadelphia
Philadelphia, Pennsylvania, 191044318
United States
Univ of Maryland at Baltimore / Univ Med Ctr
Baltimore, Maryland, 21201
United States
Schneider Children's Hosp
New Hyde Park, New York, 11040
United States
Univ of Nebraska Med Ctr
Omaha, Nebraska, 681985130
United States
Univ of Miami (Pediatric)
Miami, Florida, 33161
United States
Saint Christopher's Hosp for Children
Philadelphia, Pennsylvania, 191341095
United States
Columbus Children's Hosp
Columbus, Ohio, 432052696
United States
Chicago Children's Memorial Hosp
Chicago, Illinois, 606143394
United States
Children's Hosp of Boston
Boston, Massachusetts, 021155724
United States
Children's Hosp Pact Prog / Children's Hosp of Buffalo
Buffalo, New York, 14222
United States
Ramon Ruiz Arnau Univ Hosp / Pediatrics
Bayamon, , 00956
Puerto Rico
Montefiore Med Ctr Adolescent AIDS Program
Bronx, New York, 10467
United States
Children's Hosp of Denver
Denver, Colorado, 802181088
United States
San Juan City Hosp
San Juan, , 009367344
Puerto Rico
Bronx Lebanon Hosp Ctr
Bronx, New York, 10457
United States
Tulane Med Ctr Hosp
New Orleans, Louisiana, 70112
United States
Univ of Alabama at Birmingham Schl of Med / Pediatrics
Birmingham, Alabama, 35294
United States
George Washington Univ / Hershey Med Ctr
Washington D.C., District of Columbia, 20037
United States
Saint Jude Children's Research Hosp of Memphis
Memphis, Tennessee, 381052794
United States
Med Univ of South Carolina
Charleston, South Carolina, 294253312
United States
Univ of Tennessee / E Tennessee Comprehensive Hemophilia Ctr
Knoxville, Tennessee, 37920
United States
UCLA Med Ctr / Pediatric
Los Angeles, California, 900951752
United States
West Central Ohio Hemophilia Ctr / Children's Med Ctr
Dayton, Ohio, 454041815
United States
Children's Hosp of Washington DC
Washington D.C., District of Columbia, 200102916
United States
Univ of Florida Health Science Ctr / Pediatrics
Jacksonville, Florida, 32209
United States
Westchester Hosp
Valhalla, New York, 10595
United States
Children's Hosp of Oakland
Oakland, California, 946091809
United States
Georgetown Univ Med Ctr
Washington D.C., District of Columbia, 20007
United States
SUNY / Erie County Med Ctr at Buffalo
Buffalo, New York, 14215
United States
Mount Sinai Med Ctr
New York City, New York, 10029
United States
Additional Information:
Study ID Numbers: ACTG 220;
Study Start Date:
Record last reviewed: March 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000780
Other Hiv Infections Studies:
1. Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS
2. A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex
3. Mycophenolate Mofetil and Abacavir Treatment in HIV Patients with Failed Anti-HIV Treatment
4. Safety and Effectiveness of Combining Hydroxyurea (HU) with Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults
5. A Study of Peldesine (BCX-34) in HIV-Infected Patients
Related Studies:
Other HIV Infections Clinical Trials
Other Ohio Clinical Trials
Other Cincinnati Clinical Trials
A "Pre-Enrollment" Protocol for HIV-Infected Adolescents
|
|
|
|
|
|
|
|
